Cargando…

PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum

PF-429242 is an inhibitor of subtilisin, an important protease found in Leishmania. However, studies regarding the effect of PF-429242 on Leishmania are scarce. In this work we evaluated the antileishmanial effect of PF-429242 against Leishmania infantum and the mechanism involved in the death of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado, Patrícia de Almeida, Gomes, Pollyanna Stephanie, Midlej, Victor, Coimbra, Elaine Soares, de Matos Guedes, Herbert Leonel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876069/
https://www.ncbi.nlm.nih.gov/pubmed/33584607
http://dx.doi.org/10.3389/fmicb.2021.583834
_version_ 1783649900730253312
author Machado, Patrícia de Almeida
Gomes, Pollyanna Stephanie
Midlej, Victor
Coimbra, Elaine Soares
de Matos Guedes, Herbert Leonel
author_facet Machado, Patrícia de Almeida
Gomes, Pollyanna Stephanie
Midlej, Victor
Coimbra, Elaine Soares
de Matos Guedes, Herbert Leonel
author_sort Machado, Patrícia de Almeida
collection PubMed
description PF-429242 is an inhibitor of subtilisin, an important protease found in Leishmania. However, studies regarding the effect of PF-429242 on Leishmania are scarce. In this work we evaluated the antileishmanial effect of PF-429242 against Leishmania infantum and the mechanism involved in the death of the parasite. PF-429242 had low toxicity against mammalian cells (peritoneal macrophages) (CC(50) = 189.07 μM) and presented activity against L. infantum promastigotes (IC(50) = 2.78 μM) and intracellular amastigotes (IC(50) = 14.07 μM), indicating selectivity toward the parasite. Transmission electron microscopy (TEM), as well as staining of L. infantum promastigotes with MitoTracker(®) Red, rhodamine 123 and MitoSOX, revealed that the mitochondria was a potential target of PF-429242. In addition, PF-429242 caused an accumulation of neutral lipids in promastigotes, which was demonstrated by Nile Red staining and TEM, and induced oxidative stress (H(2)DCFDA staining). Furthermore the formation of autophagic vacuoles in L. infantum promastigotes was observed by MDC staining and TEM. However, the killing induced by PF-429242 in L. infantum promastigotes appeared to be unrelated to apoptosis and/or necrosis as there was no phosphatidylserine externalization, DNA fragmentation or alterations in the permeability of the parasite plasma membrane, as assessed by annexin V-FITC, TUNEL and propidium iodide staining, respectively. The morphological and ultrastructural evaluation of the promastigotes by optical microscopy, scanning electron microscopy (SEM) and TEM, revealed the presence of parasites with flagellar defects. TEM analysis of the intracellular amastigotes indicated that mitochondrial damage and autophagy could also be involved in the death of these forms after treatment with PF-429242. In addition, PF-429242 treatment stimulated NO production from infected macrophage, but only at a high concentration (100 μM), as well as an increase of TNF levels after treatment with 10 μM of PF-429242. The compound did not stimulate ROS or IL-10 production. Together, these data highlight the antileishmanial potential of PF-429242, inducing several cellular alterations in the parasite, such as mitochondrial damage, neutral lipids accumulation, oxidative stress and autophagy which culminate in the death of L. infantum, as well as modulating host cellular responses that favor the development of an immune response against the parasite.
format Online
Article
Text
id pubmed-7876069
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78760692021-02-12 PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum Machado, Patrícia de Almeida Gomes, Pollyanna Stephanie Midlej, Victor Coimbra, Elaine Soares de Matos Guedes, Herbert Leonel Front Microbiol Microbiology PF-429242 is an inhibitor of subtilisin, an important protease found in Leishmania. However, studies regarding the effect of PF-429242 on Leishmania are scarce. In this work we evaluated the antileishmanial effect of PF-429242 against Leishmania infantum and the mechanism involved in the death of the parasite. PF-429242 had low toxicity against mammalian cells (peritoneal macrophages) (CC(50) = 189.07 μM) and presented activity against L. infantum promastigotes (IC(50) = 2.78 μM) and intracellular amastigotes (IC(50) = 14.07 μM), indicating selectivity toward the parasite. Transmission electron microscopy (TEM), as well as staining of L. infantum promastigotes with MitoTracker(®) Red, rhodamine 123 and MitoSOX, revealed that the mitochondria was a potential target of PF-429242. In addition, PF-429242 caused an accumulation of neutral lipids in promastigotes, which was demonstrated by Nile Red staining and TEM, and induced oxidative stress (H(2)DCFDA staining). Furthermore the formation of autophagic vacuoles in L. infantum promastigotes was observed by MDC staining and TEM. However, the killing induced by PF-429242 in L. infantum promastigotes appeared to be unrelated to apoptosis and/or necrosis as there was no phosphatidylserine externalization, DNA fragmentation or alterations in the permeability of the parasite plasma membrane, as assessed by annexin V-FITC, TUNEL and propidium iodide staining, respectively. The morphological and ultrastructural evaluation of the promastigotes by optical microscopy, scanning electron microscopy (SEM) and TEM, revealed the presence of parasites with flagellar defects. TEM analysis of the intracellular amastigotes indicated that mitochondrial damage and autophagy could also be involved in the death of these forms after treatment with PF-429242. In addition, PF-429242 treatment stimulated NO production from infected macrophage, but only at a high concentration (100 μM), as well as an increase of TNF levels after treatment with 10 μM of PF-429242. The compound did not stimulate ROS or IL-10 production. Together, these data highlight the antileishmanial potential of PF-429242, inducing several cellular alterations in the parasite, such as mitochondrial damage, neutral lipids accumulation, oxidative stress and autophagy which culminate in the death of L. infantum, as well as modulating host cellular responses that favor the development of an immune response against the parasite. Frontiers Media S.A. 2021-01-28 /pmc/articles/PMC7876069/ /pubmed/33584607 http://dx.doi.org/10.3389/fmicb.2021.583834 Text en Copyright © 2021 Machado, Gomes, Midlej, Coimbra and de Matos Guedes. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Machado, Patrícia de Almeida
Gomes, Pollyanna Stephanie
Midlej, Victor
Coimbra, Elaine Soares
de Matos Guedes, Herbert Leonel
PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum
title PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum
title_full PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum
title_fullStr PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum
title_full_unstemmed PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum
title_short PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum
title_sort pf-429242, a subtilisin inhibitor, is effective in vitro against leishmania infantum
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876069/
https://www.ncbi.nlm.nih.gov/pubmed/33584607
http://dx.doi.org/10.3389/fmicb.2021.583834
work_keys_str_mv AT machadopatriciadealmeida pf429242asubtilisininhibitoriseffectiveinvitroagainstleishmaniainfantum
AT gomespollyannastephanie pf429242asubtilisininhibitoriseffectiveinvitroagainstleishmaniainfantum
AT midlejvictor pf429242asubtilisininhibitoriseffectiveinvitroagainstleishmaniainfantum
AT coimbraelainesoares pf429242asubtilisininhibitoriseffectiveinvitroagainstleishmaniainfantum
AT dematosguedesherbertleonel pf429242asubtilisininhibitoriseffectiveinvitroagainstleishmaniainfantum